Cargando…

Glucose Serum Concentrations and Cardiovascular Disease in Patients on the End Stage of Renal Disease without Diabetes Mellitus

Background/Aim: It is still controversial whether tighter glycemic control is associated with better clinical outcomes in patients with kidney failure. We examined the association between glucose serum concentrations and cardiovascular disease in patients on the end stage of renal disease without di...

Descripción completa

Detalles Bibliográficos
Autores principales:	Raikou, Vaia D., Kyriaki, Despina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2015
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5753095/ https://www.ncbi.nlm.nih.gov/pubmed/29371512 http://dx.doi.org/10.3390/jcdd2020066

Ejemplares similares

Association between Low Serum Bicarbonate Concentrations and Cardiovascular Disease in Patients in the End-Stage of Renal Disease
por: Raikou, Vaia D., et al.
Publicado: (2016)

Oxidized Low-Density Lipoprotein Serum Concentrations and Cardiovascular Morbidity in End Stage of Renal Disease †
por: Raikou, Vaia, et al.
Publicado: (2018)

The Association between Intradialytic Hypertension and Metabolic Disorders in End Stage Renal Disease
por: Raikou, Vaia D., et al.
Publicado: (2018)

Triglycerides to High-Density Lipoprotein Cholesterol Ratio Predicts Chronic Renal Disease in Patients without Diabetes Mellitus (STELLA Study)
por: Raikou, Vaia D., et al.
Publicado: (2020)

Importance of serum phosphate in elderly patients with diabetes mellitus
por: Raikou, Vaia D, et al.
Publicado: (2020)

Serum phosphate and chronic kidney and cardiovascular disease: Phosphorus potential implications in general population
por: Raikou, Vaia D
Publicado: (2021)

The relationship between glycemic control, beta2-microglobulin and inflammation in patients on maintenance dialysis treatment
por: Raikou, Vaia D, et al.
Publicado: (2015)

Metabolic Syndrome and Chronic Renal Disease
por: Raikou, Vaia D., et al.
Publicado: (2018)

Serum Concentration of Cystatin C and Risk of End-Stage Renal Disease in Diabetes
por: Krolewski, Andrzej S., et al.
Publicado: (2012)

Low serum PSA levels of diabetes mellitus-caused end-stage renal disease patients
por: Wada, Yoshihiro, et al.
Publicado: (2008)

Serum transferrin predicts end-stage Renal Disease in Type 2 Diabetes Mellitus patients
por: Zhao, Lijun, et al.
Publicado: (2020)

Cardiovascular Disease in Patients with End-Stage Renal Disease on Hemodialysis
por: Aoki, Jiro, et al.
Publicado: (2017)

Mortality and Low Serum Bicarbonate Level in Patients on Hemodiafiltration versus Peritoneal Dialysis
por: Raikou, V. D., et al.
Publicado: (2018)

Diagnosis and Management of Cardiovascular Disease in Advanced and End‐Stage Renal Disease
por: Bhatti, Navdeep K., et al.
Publicado: (2016)

Inflammation and Cardiovascular Disease Associated With Hemodialysis for End-Stage Renal Disease
por: Wang, Yinghui, et al.
Publicado: (2022)

The Urine Urokinase Concentration in End Stage Renal Disease with Acquired Renal Cyst
por: Hong, Sae Yong, et al.
Publicado: (1991)

Cardiovascular risk in children and adolescents with end stage renal disease
por: do Val, Maria Luiza, et al.
Publicado: (2019)

Serum Endocannabinoid Levels in Patients With End-Stage Renal Disease
por: Moradi, Hamid, et al.
Publicado: (2019)

Effect of Periodic Transfusion on Erythropoietin Concentration in End Stage Renal Disease
por: Hong, Sae Yong, et al.
Publicado: (1992)

Risk of Cardiovascular Diseases in Diabetes Mellitus and Serum Concentration of Asymmetrical Dimethylarginine
por: Jawalekar, Seema L., et al.
Publicado: (2013)

Blood Glucose Fluctuation in Older Adults with Diabetes Mellitus and End-Stage Renal Disease on Maintenance Hemodialysis: An Observational Study
por: Li, Jinzhu, et al.
Publicado: (2022)

Circulating proteins as predictors of cardiovascular mortality in end-stage renal disease
por: Feldreich, Tobias, et al.
Publicado: (2018)

The Impact of Diabetes Mellitus on Vascular Biomarkers in Patients with End-Stage Renal Disease
por: Moon, Jeonggeun, et al.
Publicado: (2017)

Serum Fatty Acid-Binding Protein 4 Is a Predictor of Cardiovascular Events in End-Stage Renal Disease
por: Furuhashi, Masato, et al.
Publicado: (2011)

The Kidney–Gut–Muscle Axis in End-Stage Renal Disease is Similarly Represented in Older Adults
por: Lustgarten, Michael S.
Publicado: (2019)

Association between triglyceride-glucose index and risk of end-stage renal disease in patients with type 2 diabetes mellitus and chronic kidney disease
por: Gao, Yue-Ming, et al.
Publicado: (2023)

A comparative study of serum aminotransferases in chronic kidney disease with and without end-stage renal disease: Need for new reference ranges
por: Ray, Lopamudra, et al.
Publicado: (2015)

Serum OPG and RANKL Levels as Risk Factors for the Development of Cardiovascular Calcifications in End-Stage Renal Disease Patients in Hemodialysis
por: Spartalis, Michalis, et al.
Publicado: (2023)

The triglyceride-glucose index predicts 1-year major adverse cardiovascular events in end-stage renal disease patients with coronary artery disease
por: Xie, Enmin, et al.
Publicado: (2023)

Diabetes mellitus as a cause of end-stage renal disease in Europe: signs of improvement
por: van den Brand, Jan A.J.G.
Publicado: (2016)

Serum Prolidase Activity and Oxidative Stress in Diabetic Nephropathy and End Stage Renal Disease: A Correlative Study with Glucose and Creatinine
por: Verma, Akhilesh Kumar, et al.
Publicado: (2014)

Effects of Variability in Blood Pressure, Glucose, and Cholesterol Concentrations, and Body Mass Index on End-Stage Renal Disease in the General Population of Korea
por: Kim, Mee Kyoung, et al.
Publicado: (2019)

Differing myocardial response to a single session of hemodialysis in end-stage renal disease with and without type 2 diabetes mellitus and coronary artery disease
por: Govind, Satish Chandra, et al.
Publicado: (2006)

Preliminary study of hypoxia-related cardiovascular mediator-markers in patients with end-stage renal disease with and without diabetes and the effects of haemodialysis
por: Treweeke, A., et al.
Publicado: (2017)

End Stage Renal Disease and Medicare
por: Greer, Joel W.
Publicado: (2003)

Dietary Protein and Physical Activity Interventions to Support Muscle Maintenance in End-Stage Renal Disease Patients on Hemodialysis
por: Hendriks, Floris K., et al.
Publicado: (2019)

End-Stage renal disease and 30-day mortality for adults with and without COVID-19
por: Harrison, Stephanie L., et al.
Publicado: (2021)

Sacubitril/valsartan in patients with heart failure with reduced ejection fraction with end‐stage of renal disease
por: Lee, Seonhwa, et al.
Publicado: (2020)

Impact of Diabetes Mellitus on the Risk of End-Stage Renal Disease in Patients with Systemic Lupus Erythematosus
por: Jiang, Ming-Yan, et al.
Publicado: (2018)

Vitamin D Deficiency in End Stage Renal Disease Patients with Diabetes Mellitus Undergoing Hemodialysis
por: Ali, Muhammad, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_f8rop32lb56dju51a4viqqhp36